AR

Anand Rajaram Prassanna

Active Director Director DIN 08207625
DIN 08207625 First appointment Aug 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value •••• Premium profile

About Anand Rajaram Prassanna

Data last updated:

Anand Rajaram Prassanna is a Director at Victus Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Victus Pharmaceutical Private Limited reported revenue of ₹63 Lakh (FY 2025).

DIN 08207625
Primary Designation Director
Industry Pharma
First Appointment 27 Aug 2018
Oldest Company Age 13 yrs
Largest company Victus Pharmaceutical Private Limited · ₹63 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Aug 20182013₹63 Lakh (FY 2025)Active

Board colleagues of Anand Rajaram Prassanna

NameDINCompanyDesignation
Narayanan Rajaram06473961Victus Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Victus Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Anand Rajaram Prassanna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Rajaram Prassanna

Anand Rajaram Prassanna currently holds 1 directorship: Victus Pharmaceutical Private Limited (Director, since 27 Aug 2018, revenue ₹63 Lakh (FY 2025)).

Anand Rajaram Prassanna was first appointed on 27 Aug 2018 as Director at Victus Pharmaceutical Private Limited.

The current boards of Anand Rajaram Prassanna's companies include Narayanan Rajaram (Victus Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available